BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

389 related articles for article (PubMed ID: 31082822)

  • 1. Use of biologics in chronic sinusitis with nasal polyps.
    Wang C; Zhang L
    Curr Opin Allergy Clin Immunol; 2019 Aug; 19(4):365-372. PubMed ID: 31082822
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Role of Biologics in Chronic Rhinosinusitis With Nasal Polyps.
    Patel GB; Peters AT
    Ear Nose Throat J; 2021 Jan; 100(1):44-47. PubMed ID: 33035132
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chronic rhinosinusitis with nasal polyps management in the age of biologics.
    Blaiss MS
    Allergy Asthma Proc; 2020 Nov; 41(6):413-419. PubMed ID: 33109306
    [No Abstract]   [Full Text] [Related]  

  • 4. The Role of Biologics in the Treatment of Nasal Polyps.
    Franzese CB
    Immunol Allergy Clin North Am; 2020 May; 40(2):295-302. PubMed ID: 32278452
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Current and emerging biological therapies for Chronic rhinosinusitis with nasal polyps with type 2 inflammation.
    Jin Z; Yan B; Zhang L; Wang C
    Expert Opin Investig Drugs; 2023; 32(10):909-919. PubMed ID: 37855222
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Critical Look at the Efficacy and Costs of Biologic Therapy for Chronic Rhinosinusitis with Nasal Polyposis.
    Brown WC; Senior B
    Curr Allergy Asthma Rep; 2020 Apr; 20(6):16. PubMed ID: 32323067
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatable traits in chronic rhinosinusitis with nasal polyps.
    Heffler E; Malvezzi L; Pirola F; Zięba N; Paoletti G; Mercante G; Spriano G; Canonica GW
    Curr Opin Allergy Clin Immunol; 2019 Aug; 19(4):373-378. PubMed ID: 31135395
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Systematic literature review of the epidemiology and clinical burden of chronic rhinosinusitis with nasal polyposis.
    Chen S; Zhou A; Emmanuel B; Thomas K; Guiang H
    Curr Med Res Opin; 2020 Nov; 36(11):1897-1911. PubMed ID: 32847417
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The perspectives of biologics in the treatment of chronic rhinosinusitis with nasal polyps].
    Zhang L
    Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2023 Nov; 37(11):853-855. PubMed ID: 37905479
    [No Abstract]   [Full Text] [Related]  

  • 10. Biologics in chronic rhinosinusitis with nasal polyposis.
    Laidlaw TM; Buchheit KM
    Ann Allergy Asthma Immunol; 2020 Apr; 124(4):326-332. PubMed ID: 31830587
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biologics for chronic rhinosinusitis with nasal polyps (CRSwNP).
    Scadding GK; Scadding GW
    J Allergy Clin Immunol; 2022 Mar; 149(3):895-897. PubMed ID: 34752829
    [No Abstract]   [Full Text] [Related]  

  • 12. Role of Biologics in Chronic Rhinosinusitis With Nasal Polyposis: State of the Art Review.
    Kim C; Han J; Wu T; Bachert C; Fokkens W; Hellings P; Hopkins C; Lee S; Mullol J; Lee JT
    Otolaryngol Head Neck Surg; 2021 Jan; 164(1):57-66. PubMed ID: 32746710
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biomarkers guiding biological therapeutic strategies in chronic rhinosinusitis with nasal polyps: an emerging challenge.
    Yan B; Zhang L
    Expert Rev Clin Immunol; 2023; 19(8):827-830. PubMed ID: 37114372
    [No Abstract]   [Full Text] [Related]  

  • 14. Chronic rhinosinusitis with nasal polyps: insights into mechanisms of disease from emerging biological therapies.
    Kariyawasam HH
    Expert Rev Clin Immunol; 2019 Jan; 15(1):59-71. PubMed ID: 30370785
    [No Abstract]   [Full Text] [Related]  

  • 15. Pathogenesis-based application of biologics for chronic rhinosinusitis: Current and future perspectives.
    Okano M; Kanai K; Oka A
    Auris Nasus Larynx; 2024 Apr; 51(2):371-378. PubMed ID: 37743131
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The argument against the use of dupilumab in patients with limited polyp burden in chronic rhinosinusitis with nasal polyposis (CRSwNP).
    Hardison SA; Senior BA
    J Otolaryngol Head Neck Surg; 2023 Sep; 52(1):64. PubMed ID: 37759322
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Type 2 Biomarkers for the Indication and Response to Biologics in CRSwNP.
    Guo CL; Liu FF; Wang DY; Liu Z
    Curr Allergy Asthma Rep; 2023 Dec; 23(12):703-713. PubMed ID: 37987873
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endotype-driven precision medicine in chronic rhinosinusitis.
    Lou H; Wang C; Zhang L
    Expert Rev Clin Immunol; 2019 Nov; 15(11):1171-1183. PubMed ID: 31600458
    [No Abstract]   [Full Text] [Related]  

  • 19. The Role of Biologics in the Treatment of Chronic Rhinosinusitis.
    Haloob N; Karamali K; Hopkins C
    BioDrugs; 2023 Jul; 37(4):477-487. PubMed ID: 37318659
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chinese Expert Consensus on the Use of Biologics in Patients with Chronic Rhinosinusitis (2022, Zhuhai).
    Hong HY; Chen TY; Yang QT; Sun YQ; Chen FH; Lou HF; Wang HT; Yu RL; An YF; Liu F; Wang TS; Lu MP; Qiu QH; Wang XD; Chen JJ; Meng CD; Xie ZH; Meng J; Zeng M; Xu CL; Wang Y; Yang YC; Zhang WT; Tang J; Yang YL; Xu R; Yu GD; Shi ZH; Wei X; Ye HP; Sun YN; Yu SQ; Zhang TH; Yong J; Hang W; Xu YT; Xu Y; Tan GL; Sun N; Yang G; Li YJ; Ye J; Zuo KJ; Zhang LQ; Wang XY; Yang AN; Xu YX; Liao W; Fan YP; Li HB
    ORL J Otorhinolaryngol Relat Spec; 2023; 85(3):128-140. PubMed ID: 37019094
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.